These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9872270)

  • 21. [Gastric lesion caused by NSAID and inflammation due to Helicobacter pylori. Is there potentiation or attenuation?].
    Lanas Arbeloa A; Serrano Aulló MT
    Gastroenterol Hepatol; 1998 Jan; 21 Suppl 1():20-4. PubMed ID: 9549198
    [No Abstract]   [Full Text] [Related]  

  • 22. Helicobacter pylori, NSAIDs, and peptic ulcers.
    Hawkey CJ; Yeomans ND; Gillon K
    Lancet; 1998 Jan; 351(9095):61; author reply 61-2. PubMed ID: 9433439
    [No Abstract]   [Full Text] [Related]  

  • 23. Specifics of Helicobacter pylori infection/NSAID effects in the elderly.
    Davidovic M; Svorcan P; Milanovic P; Antovic A; Milosevic D
    Rom J Gastroenterol; 2005 Sep; 14(3):253-8. PubMed ID: 16200236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S; Ittel TH; Wietholtz H
    Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What do we do about Helicobacter pylori?
    Hawkey CJ
    Can J Gastroenterol; 1999 Mar; 13(2):143-5. PubMed ID: 10203433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapies for ulcers associated with nonsteroidal antiinflammatory drugs.
    Weilert F; Smith AC; Stokes PL
    N Engl J Med; 1998 Jul; 339(5):349; author reply 350-1. PubMed ID: 9696649
    [No Abstract]   [Full Text] [Related]  

  • 27. [Helicobacter pylori infection in peptic ulcer disease].
    Takeda H; Asaka M
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():13-8. PubMed ID: 11979764
    [No Abstract]   [Full Text] [Related]  

  • 28. Helicobacter pylori, NSAIDs, and peptic ulcers.
    Jolobe OM
    Lancet; 1998 Jan; 351(9095):61; author reply 61-2. PubMed ID: 9433440
    [No Abstract]   [Full Text] [Related]  

  • 29. Helicobacter pylori eradication: kill the bug and save the pill?
    Jeffries MA; Scheiman JM; Fendrick AM
    Am J Gastroenterol; 1998 Jul; 93(7):1183-4. PubMed ID: 9672364
    [No Abstract]   [Full Text] [Related]  

  • 30. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
    Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonsteroidal anti-inflammatory drugs, Helicobacter pylori, and ulcers: where we stand.
    Graham DY
    Am J Gastroenterol; 1996 Oct; 91(10):2080-6. PubMed ID: 8855725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Peptic ulcer disease etiology, diagnosis and treatment].
    Bak-Romaniszyn L; Wojtuń S; Gil J; Płaneta-Małecka I
    Pol Merkur Lekarski; 2004; 17 Suppl 1():128-32. PubMed ID: 15603370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eradication of Helicobacter pylori infection reduces the incidence of peptic ulcer disease in patients using nonsteroidal anti-inflammatory drugs: a meta-analysis.
    Tang CL; Ye F; Liu W; Pan XL; Qian J; Zhang GX
    Helicobacter; 2012 Aug; 17(4):286-96. PubMed ID: 22759329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
    de Leest HT; Steen KS; Lems WF; Bijlsma JW; van de Laar MA; Huisman AM; Vonkeman HE; Houben HH; Kadir SW; Kostense PJ; van Tulder MW; Kuipers EJ; Boers M; Dijkmans BA
    Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [NSAID-gastropathy and Helicobacter pylori: more questions than answers].
    Shirinskaia NV; Akhmedov VA
    Eksp Klin Gastroenterol; 2010; (9):116-20. PubMed ID: 21427936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The analysis of the recurrence ulcer after H. pylori eradication].
    Kamada T; Chayama K; Haruma K; Yoshihara M; Ito M; Kitadai Y; Kawamura Y
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():501-5. PubMed ID: 11979837
    [No Abstract]   [Full Text] [Related]  

  • 38. New treatments for peptic ulcer disease.
    Cornell S
    Adv Nurse Pract; 1997 Mar; 5(3):57-9. PubMed ID: 9459883
    [No Abstract]   [Full Text] [Related]  

  • 39. Helicobacter pylori and non-malignant diseases.
    Rokkas T; Simsek I; Ladas S
    Helicobacter; 2007 Oct; 12 Suppl 1():20-2. PubMed ID: 17727456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NSAIDs and aspirin: notorious or FAMOUS?
    Hawkey CJ
    Lancet; 2009 Jul; 374(9684):93-4. PubMed ID: 19577799
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.